Search results
Integrating Advanced Connected Care Technologies into the Care Continuum
In the last few years, the number of advanced connected care technologies has proliferated, from telehealth and RPM to digital therapeutics and VR.
However, their success depends on numerous factors, including seamless integration into clinical workflows, provider buy-in, and patient education. During
this panel discussion, leaders from provider and payer organizations will discuss barriers to successful technology integration, strategies to break down thos…
Gen-AI/AGI - How have these technological advances changed cybersecurity risk identification and
mitigation approaches?
The goal of this session is to equip the attendees with the perspectives to consider when analyzing the risks in the Gen-AI/AGI space and the mitigation
approaches. We will start by identifying the threats and risks from a different lens that accounts for the impacts on our professional and personal lives and
how they may be intertwined. We will then walk through analytical methods to identify and implement mitigating controls. We will conclude with some exam…
Digital therapeutics and healthcare innovation
Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement
traditional medical approaches and augment patient care. The development of software applications that are available with a prescription took a major step
forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label. At the same time as digital therapeutics …
PDURS explained: The FDA’s new framework for adding software to drug labels
The new PDURS framework is poised to change the way pharma thinks about companion apps, digital medicines, and digital therapeutics. However, to unlock
its potential, digital leaders in the pharma industry need to know what the framework is, how it works, and how it can be of use to them. Benefit from our
speakers’ unique perspectives at the intersection of pharma and government as you get the skinny on this new way of regulating drug-related apps.
The Digital Great Wall: Data Protection in Today’s China
China’s emerging statutes and regulations governing the processing, disclosure and transfer of data, under threat of severe penalties, pose significant risks
for producing parties. Yet, as Chinese entities increasingly become global commercial players, data located in China becomes increasingly relevant to U.S.
disputes and investigations. Our expert panel will discuss the challenges of dealing with requests to produce information located in China, and strategies for…
How is Artificial Intelligence Defining the Future of Drug Discovery?
We hear about Artificial Intelligence (AI) all the time, but how is AI shaping the future of drug discovery? The use of AI within the pharma industry is set to
have a major impact on driving forward the discovery of new drugs more quickly, efficiently and cheaply than traditional approaches. In this webinar, Anne
and Stephen will be joined by Ivan Griffin of BenevolentAI, Laksh Aithani of Charm Therapeutics and Peter Kulka of Goldman Sachs and will discuss the oppo…
Accelerating Digital Therapeutics Development on AWS
In our highly connected world, patients now expect pharma companies to provide them with enhanced customer experiences, tools, and services to assist in
their patient journey and help them to get better faster. In order to provide better patient care, organizations have been innovating with digital medicine.
Enter digital therapeutics. Digital therapeutics (DTx) are evidence-based software such as a mobile application, a digitally connected medicine, or a conne…
Decoding physician prescribing behaviour: A data-driven journey
In this webinar, you’ll hear how to identify physicians who are prescribing competing drugs or treating a high number of patients, and discover which
medications and treatment combinations are being used by physicians in key therapeutic areas.
L.E.K. Look Forward: Three trends driving growth in the consumer health sector
Adrienne Rivlin looks at the three trends driving the consumer health sector. Watch her to learn how self-care is containing costs and increasing capacity,
vitamin supplements and digital therapeutics are helping to improve mental wellbeing, and the rise of home diagnostics and convenience culture are
radically altering the way we access and interact with healthcare.